§211.89. Rejected components, drug product containers, and closures.
21 C.F.R. § 211.89
Rejected components, drug product containers, and closures shall be identified and controlled under a quarantine system designed to prevent their use in manufacturing or processing operations for which they are unsuitable.
Notes, amendments, and revision history
Authority
Authority: 21 U.S.C. 321, 351, 352, 355, 360b, 360ddd, 360ddd-1, 371, 374; 42 U.S.C. 216, 262, 263a, 264.
Source
Source: 43 FR 45077, Sept. 29, 1978, unless otherwise noted.